Publication: Pediatric non-Hodgkin lymphoma: Characteristics, stratification, and treatment at a single institute in Thailand
Issued Date
2019-01-01
Resource Type
ISSN
1442200X
13288067
13288067
Other identifier(s)
2-s2.0-85061285938
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Pediatrics International. Vol.61, No.1 (2019), 49-57
Suggested Citation
Worawut Choeyprasert, Usanarat Anurathapan, Samart Pakakasama, Nongnuch Sirachainan, Duantida Songdej, Surapong Lertthammakiat, Suradej Hongeng Pediatric non-Hodgkin lymphoma: Characteristics, stratification, and treatment at a single institute in Thailand. Pediatrics International. Vol.61, No.1 (2019), 49-57. doi:10.1111/ped.13739 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/52282
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Pediatric non-Hodgkin lymphoma: Characteristics, stratification, and treatment at a single institute in Thailand
Other Contributor(s)
Abstract
© 2018 Japan Pediatric Society Background: In the modern era of chemotherapy, the outcome of pediatric non-Hodgkin lymphoma (NHL) continues to improve internationally. Limited data such as information on epidemiology and survival, however, are available in Asian countries. Methods: Children (≤15 years old) diagnosed with histologically proven NHL from 1998 to 2014 were retrospectively analyzed. Results: In total, 114 patients were enrolled; they were predominantly male (65.8%) and had advanced disease (stage III, IV; 71.9%). Of these, 22.8% had Burkitt lymphoma, 20.2% had diffuse large B-cell lymphoma, 21.1% had lymphoblastic lymphoma, 20.2% had large cell lymphoma, and 15.8% had peripheral T-cell lymphoma. Twenty-nine patients died, especially of uncontrolled disease (62.1%) and infection (20.7%). During a median follow up of 78.4 months, Kaplan–Meier 5 year event-free and overall survival rates were 71.5% ± 4.3% and 74.8% ± 4.1%, respectively, regardless of subtype. B symptoms (i.e. systemic symptoms of fever, night sweats, and weight loss that can be associated with both Hodgkin's lymphoma and non-Hodgkin's lymphoma) and advanced disease had a significant negative impact on 5 year survival. No other prognostic factor was found, but survival tended to have a negative correlation with age. Conclusions: Pediatric NHL is aggressive, with a high prevalence of peripheral T-cell lymphoma. The present treatment stratification seems to be effective compared with that used in developed countries.